ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Synovitis"

  • Abstract Number: 1840 • ACR Convergence 2024

    Synovial Resident Memory T Cell Formation During Inflammation Requires Cell Contact with Fibroblast-Like Synoviocytes

    Yusuke Miyashita1, Yang Yang1, Madison Mangin1, Maryrose Hahn2, Kevin Wei3, Peter Nigrovic4 and Margaret Chang1, 1Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, Georgetown, MA, 3Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 4Boston Children's Hospital, Brookline, MA

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by recurrent inflammation in the same joints, a feature termed joint-specific memory. We previously demonstrated…
  • Abstract Number: 1959 • ACR Convergence 2024

    A 3-arm, Randomized, Open-label, Parallel Active Controlled, Multicentre International Study to Compare the Response of Ultrasound-assessed Synovitis to Baricitinib, Alone and Combined with Methotrexate versus Etanercept in Rheumatoid Arthritis Patients

    ESPERANZA NAREDO1, Otto Olivas-Vergara2, Pablo E. Borges2, Sheila Recuero-Díaz2, Fernando Saraiva3, Joana Martinho3, Filipa Costa3, Catarina Tenazinha3, Margarida Monteiro3, Ana Teresa Melo3, Ana Rodriguez-García4, Carlos A. Guillén-Astete5, Boris A. Blanco-Cáceres4, Alina L. Boteanu4, Antonio Mera-Varela6, Eva Pérez Pampín6, Yolanda López Golán6, Cristina Campos Fernández7, Jorge Juan Fragío Gíl7, roxana gonzalez mazarío7, Juan José De Agustín8, Gustavo Añez Sturchio9, Luis Coronel Tarancon8, Esther Vicente-rabaneda10, Santos Castañeda10, Irene Llorente-Cubas10, Maria S. Stoenoiu11, NZEUSSEU TOUKAP Adrien12, Ilaria Padovano13, Helene Gouze13, Ariane Leboime13, Maxime Breban14, Jaqueline Uson15, Virginia Villaverde16, Martina Steiner17, Cristina Vergara Dangond17, Maria Beatriz Paredes Romero17, Santiago Muñoz Fernández18, Carolina Pérez-García19, Juan Antonio Meraz-Ostiz19, Stephanie Finzel20, Anna-Maria Kanne21, Aránzazu Mediero22, Carmen Herencia23, Gabriel Herrero-Beaumont24 and Raquel Largo22, 1Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 2Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD, Madrid, Spain, 3Rheumatology Department, Unidade Local de Saúde de Santa Maria. Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal, 4Rheumatology Department. Ramón y Cajal University Hospital, Madrid, Spain, 5Rheumatology Department. Ramon y Cajal University Hospital, Madrid, Spain, 6Department of Rheumatology. Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain, 7Department of Rheumatology. Hospital General Universitario de Valencia, Valencia, Spain, 8Image and Technics Unit, Department of Rheumatology. Hospital Universitari Vall d’Hebron, Barcelona, Spain, 9Department of Rheumatology. Hospital Arnau de Vilanova, Lleida, Spain, 10Hospital Universitario de La Princesa, Madrid, Spain, 11Cliniques Universitaires Saint-Luc, Brussels, Belgium, 12Institut de Recherche Expérimentale et Clinique, Cliniques universitaires Saint-Luc, Université catholique de Louvain, St.-Lambrechts-Woluwe, Belgium, 13Departement of Rheumatology, Hopital Ambroise Paré, Boulogne-Billancourt, Spain, 14Departement of Rheumatology, Hopital Ambroise Paré, Departement of Rheumatology, Hopital Ambroise Paré, Spain, 15Department of Rheumatology, Hospital Universitario de Móstoles. University Rey Juan Carlos, Madrid, Spain, 16Department of Rheumatology, Hospital Universitario de Móstoles, Madrid, Spain, 17Department of Rheumatology. Hospital Universitario Infanta Sofía., Madrid, Spain, 18Hospital Universitario Infanta Sofía. Universidad Europea de Madrid, Madrid, Spain, 19Department of Rheumatology, Hospital del Mar of Barcelona, Barcelona, Spain, 20Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Freiburg, DE, Freiburg im Breisgau, Germany, 21Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany, 22Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, Madrid, Spain, 23Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, M, Spain, 24Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain

    Background/Purpose: To demonstrate non-inferiority of the response of musculoskeletal ultrasound (MSKUS)-assessed synovitis to baricitinib, alone and plus MTX vs. etanercept plus MTX in patients with…
  • Abstract Number: 2244 • ACR Convergence 2024

    Unveiling Synovial Protein Contributions to Serum Inflammation, Disease Activity, and Treatment Outcomes in RA Patients

    Chary Lopez-Pedrera1, Sagrario Corrales2, Julio Osuna3, Rafaela Ortega-Castro4, Jerusalén Calvo3, María Lourdes Ladehesa-Pineda1, Ismael Sánchez Pareja2, Laura Muñoz-Barrera2, Desiree Ruiz-Vilchez3, Christian Merlo5, Mª Angeles Aguirre-Zamorano6, Nuria Barbarroja2, Tomás Cerdó2, Rosa ortega3, Marta Alarcon-Riquelme7, Carlos Perez-Sanchez2, Alejandro Escudero-Contreras2 and Concepción Aranda-Valera8, 1IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Andalucia, Spain, 2IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 4Hospital Reina Sofía, Cordoba, Andalucia, Spain, 5Rheumatology Service, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain, 6IMIBIC/Reina Sofia Hospital/University of Cordoba, CÓRDOBA, Andalucia, Spain, 7Fundación Progreso y Salud, Andalusian Government, Granada, Spain, 8IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Andalucia, Spain

    Background/Purpose: Characterize synovial tissue-secreted proteins in RA patients that contibute to serum inflammatory profiles based on immune cell infiltration.Identify RA patient subsets with distinctive serum…
  • Abstract Number: 2331 • ACR Convergence 2024

    Assessment of the Likelihood of Joint Inflammation Recurrence in Previously Affected Joints During Psoriatic Arthritis Disease Course

    Dafne Capelusnik1, Ori Elkayam2 and Mark Berman3, 1Tel Aviv Sourasky Medical Center, Ramat Gan, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Kefar sava, Israel

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can cause joint pain, swelling, and stiffness. Patients often experience flares followed by periods of remission.…
  • Abstract Number: 2637 • ACR Convergence 2024

    Chaperone-mediated Autophagy in Synovitis Distinguishes Psoriatic Arthritis from Rheumatoid Arthritis

    Vincenzo Venerito1, Gerardo Cazzato2, Fabio Cacciapaglia3, Eleonora Ceglie4, Sergio Del Vescovo4, Teresa Caferri4, Giuseppe Lopalco4, Francesco Girolamo5 and Florenzo Iannone1, 1Rheumatology Unit- University of Bari "Aldo Moro", IT, Bari, Italy, 2Pathology Unit - University of Bari "Aldo Moro", IT, Bari, Italy, 3Rheumatology Unit � DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 4Rheumatology Unit - University of Bari "Aldo Moro", IT, Bari, Italy, 5Human Anatomy Department - University of Bari "Aldo Moro", IT, Bari, Italy

    Background/Purpose: Recent studies have suggested that autophagy may play different roles in the pathogenesis of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Lysosome-associated membrane protein type 2A…
  • Abstract Number: L05 • ACR Convergence 2023

    DICKENS: A Multicentre Randomised Controlled Trial of Diacerein for Knee Osteoarthritis with Effusion-Synovitis

    Guoqi Cai1, Graeme Jones2, Flavia Cicuttini3, Anita Wluka3, Yuanyuan Wang3, Catherine Hill4, Helen Keen5, Benny Antony2, barbara de Graaff2, Michael Thompson2, Tania Winzenberg2, Kathy Buttigieg2, Petr Otahal2 and Dawn Aitken2, 1School of Public Health, Anhui Medical University, Hefei, China, 2Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 3Monash University, Melbourne, Australia, 4The Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia, 5Fiona Stanley Hospital, Murdoch, Australia

    Background/Purpose: There is an unmet need for treatments of knee OA. Diacerein is recommended for alleviating pain in OA patients for its anti-inflammatory effect by…
  • Abstract Number: 1046 • ACR Convergence 2023

    The Level of RF or Anti-CCP Antibody Affect Ultrasound Synovial Findings in Patients with Rheumatoid Arthritis?

    Tadashi Okano1, Kenji Mamoto1, Yutaro Yamada1, Shohei Anno2, Yuka Domae1, Shingo Washida1, Asami Yagami1, Yuko Yoshida1, Tatsuya Koike3 and Hiroaki Nakamura1, 1Osaka Metropolitan University, Osaka, Japan, 2Yodogawa Christian Hospital, Osaka, Japan, 3Search Institute for Bone and Arthritis Disease (SINBAD), Shirahama Foundation for Health and Welfare, Shirahama, Japan

    Background/Purpose: Positive for auto-antibodies such as rheumatoid factor (RF) and anti-citrullinated peptide antibodies (CCP) or having high autoantibody titers is associated with the progression of…
  • Abstract Number: 1051 • ACR Convergence 2023

    Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis

    sibel aydin1, seyyid acikgoz2, Ummugulsum Oguz3, antonio Vieira4, patrick Leclerc4, Suharsh Shah4, Lihi Eder5 and Gurjit S Kaeley6, 1University of Ottawa - Ottawa, Ottawa, ON, Canada, 2University of Ottawa, Rheumatology, Ottawa, ON, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada, 5Women’s College Research Institute, Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 6University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Ultrasonography (US) has experienced a rapid evolution in rheumatology. Despite many advantages being shown repeatedly, several barriers persist and stand in the way of…
  • Abstract Number: 1342 • ACR Convergence 2023

    The Delivery of the Super-repressor IκBα by Exosomes Has the Potential to Alleviate Inflammation Associated with Rheumatoid Arthritis

    Ki-Jeong Park1, Ji-Hyoun Kang1, Hae-In Lee2, Yu Jeong Lee1, Moon-Ju Kim1, So-Hee Ahn3, Jae-Kwang Yoo3, Chulhee Choi3 and Tae-jong Kim4, 1Chonnam National University Hospital, Gwangju, South Korea, 2Chonnam National University, Gwangju, South Korea, 3ILIAS Biologics, Daejeon, South Korea, 4Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwang-Ju, South Korea

    Background/Purpose: Rheumatoid arthritis (RA) is a persistent inflammatory disease primarily affecting the diarthrodial joints. Nuclear factor-κB (NF-κB) is a family of inducible transcription factors responsible…
  • Abstract Number: 1594 • ACR Convergence 2023

    Oral Delivery of Δ9-Tetrahydrocannabinol Provides Symptom and Disease Modification in a Mouse Model of Knee Osteoarthritis

    Jason rockel1, Anca Maglaviceanu2, Helena Fetter Filippini3, Ewa Wasilewski4, Melissa M. Lewis-Bakker4, Sarah Gabrial1, Evgeny Rossomacha1, Johana Garcia1, Nizar Mahomed5, Timothy Leroux5, Hance Clarke6, Robert P. Bonin3, Lakshmi P. Kotra7 and Mohit Kapoor1, 1Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network, Toronto, ON, Canada, 2Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, 3Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, 4Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 5Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 6Krembil Research Institute, and Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada, 7Krembil Research Institute, University Health Network; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Osteoarthritis (OA) results in joint pain, cartilage degeneration, and synovitis. Recent studies suggest that some OA patients are self-medicating with cannabis. Δ9-tetrahydrocannabinol (THC) is…
  • Abstract Number: 0385 • ACR Convergence 2023

    Heterogeneity of the Joint Location Supports the Importance of Local Factors in Early RA Synovitis : Analysis of the ERA UCLouvain Brussels Cohort

    Laura BRICMAN1, clement triaille2, Francesco Natalucci3, Emilie Sapart2, Tatiana Sokolova4, Aleksandra AVRAMOVSKA1, Thomas KIRCHGESNER5 and Patrick Durez2, 1Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 3UCLouvain University, Sermoneta, Italy, 4Université Catholique de Louvain, Brussels, Belgium, 5Rheumatology, Cliniques Universitaires Saint-Luc Département d'imagerie médicale – Université catholique de Louvain (UCLouvain), Brussels, Belgium

    Background/Purpose: ERA is considered to be a systemic disorder, but the role of local factors in driving synovial inflammation is increasingly being recognized. These joint-specific…
  • Abstract Number: 1721 • ACR Convergence 2023

    The Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid Arthritis

    shane Bruckner1, Braden Zeno2, Vittoria Capria1, William Willis3, Latha Prabha Ganesan1 and wael Jarjour1, 1Ohio State University, Columbus, OH, 2Ohio State University, Upper Arlington, OH, 3Ohio State University, Reynoldsburg, OH

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that leads to progressive joint destruction involving multiple joints. There is a large body of…
  • Abstract Number: 0399 • ACR Convergence 2023

    Differential Synovial Tissue Enrichment of Oxylipins and Their Mediators Across Rheumatoid Arthritis Trajectory

    Simone Perniola1, Jessica Murillo-Saich2, Barbara Tolusso3, Clara Di Mario3, Marco Gessi4, Dario Bruno5, Luca Petricca6, Maria Rita Gigante6, Elisa Gremese5, Monica Guma7 and Stefano Alivernini8, 1Division of Clinical Immunology – Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 2Department of Medicine, University of California San Diego, La Jolla, CA, 3Immunology Research Core Facility – Gemelli Science and Technology Park (GSTeP) - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 4Division of Pathology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 5Division of Rheumatology, Institute of Rheumatology and Affine Sciences, School of Medicine, Catholic University of the Sacred Heart, Roma, Italy, 6Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 7University of California San Diego, La Jolla, CA, 8Immunology Research Core Facility, Gemelli Science and Technology Park, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Synovial membrane represents the target tissue of Rheumatoid Arthritis (RA) inflammation. Our study aimed to perform a comprehensive quantification of oxylipins and their precursors…
  • Abstract Number: 1727 • ACR Convergence 2023

    Arthritogenicity of Homocitrullinated Peptides in HLA-DRB1 Transgenic Mice

    Sheri Saunders, Garth Blackler, Patti Kiser, Ewa Cairns and Lillian Barra, Western University, London, ON, Canada

    Background/Purpose: Most rheumatoid arthritis (RA) patients express autoantibodies to post-translationally modified antigens, including citrullinated and homocitrullinated (also known as carbamylated) peptides. Homocitrulline and citrulline are…
  • Abstract Number: 0401 • ACR Convergence 2023

    Resolution of Swollen Joint Count Is an Important Clinical Objective in Early Rheumatoid Arthritis : Analysis of the UCLouvain Brussels ERA Cohort and Comparison with the Remission Composite Index

    Francesco Natalucci1, clement triaille2, Emilie Sapart2, Laura BRICMAN3, Cécile VAN MULLEM2, Charlotte Desmet2, Stéphanie DIERCKX4, Marie DOYEN2, Tatiana Sokolova5, Aleksandra AVRAMOVSKA3 and Patrick Durez2, 1UCLouvain University, Sermoneta, Italy, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 3Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 4CHU UCL Namur, Rheumatology, Mont-Godinne, Belgium, Mont Godinne, Belgium, 5Université Catholique de Louvain, Brussels, Belgium

    Background/Purpose: Rheumatoid Arthritis is a chronic autoimmune disease characterized by persistent joint inflammation. According to international guidelines, the treatment target should aim to reach the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology